Loading...
Prospective replication study implicates the catechol-O-methyltransferase Val(158)Met polymorphism as a biomarker for the response to morphine in patients with cancer
Genetic differences in humans cause clinical difficulties in opioid treatment. Previous studies indicate that a single nucleotide polymorphism in the catechol-O-methyltransferase (COMT) gene (rs4680; p.Val(158)Met) may present as a predictive biomarker for the response to morphine treatment. In our...
Na minha lista:
| Udgivet i: | Biomed Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590034/ https://ncbi.nlm.nih.gov/pubmed/28928973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2017.963 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|